Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
Add more filters

Publication year range
1.
Vet Radiol Ultrasound ; 65(3): 203-207, 2024 May.
Article in English | MEDLINE | ID: mdl-38357787

ABSTRACT

A 14-year-old intact female diabetic dog presented with seizures and hyperglycemic hyperosmolar syndrome. Radiographs revealed gas-filled tubular structures in the right and left caudal abdomen, raising concerns of emphysematous pyometra or small intestinal ileus. Ultrasonography played a pivotal role in confirming emphysematous pyometra, a technique previously documented only once in veterinary practice. This report also presents the first documented case of emphysematous pyometra in a diabetic dog attributed to Klebsiella pneumoniae and complicated by emphysematous hepatitis.


Subject(s)
Dog Diseases , Klebsiella Infections , Klebsiella pneumoniae , Pyometra , Animals , Dogs , Klebsiella Infections/veterinary , Klebsiella Infections/diagnosis , Klebsiella Infections/complications , Female , Dog Diseases/diagnostic imaging , Dog Diseases/microbiology , Dog Diseases/diagnosis , Klebsiella pneumoniae/isolation & purification , Pyometra/veterinary , Pyometra/complications , Pyometra/diagnostic imaging , Emphysema/veterinary , Emphysema/diagnostic imaging , Ultrasonography/veterinary , Hepatitis, Animal/diagnosis , Hepatitis, Animal/microbiology , Hepatitis, Animal/diagnostic imaging , Hepatitis, Animal/complications , Diabetes Complications/veterinary , Anti-Bacterial Agents/therapeutic use
2.
Vet Radiol Ultrasound ; 61(6): E64-E68, 2020 Nov.
Article in English | MEDLINE | ID: mdl-29998611

ABSTRACT

A 5-year-old castrated male Domestic Shorthair cat presented for evaluation of chronic history of nasal discharge and nasal stridor. On computed tomography (CT), a destructive ill-defined mass of soft tissue attenuation was occupying the right nasal cavity and extending into the left nasal cavity, nasopharynx, and rostral cranial cavity. Histopathology of the rhinoscopically excised samples consisted with destructive granulomatous rhinitis secondary to Leishmania spp. Chronic granulomatous rhinitis with intracranial and nasopharyneal extension secondary to Leishmania spp. infection should be included as a differential diagnosis for a destructive nasal mass of soft tissue attenuation, especially in endemic regions for leishmaniasis.


Subject(s)
Cat Diseases/diagnostic imaging , Granuloma/veterinary , Leishmaniasis/veterinary , Rhinitis/veterinary , Allopurinol/therapeutic use , Animals , Antiprotozoal Agents/therapeutic use , Cats , Diagnosis, Differential , Granuloma/complications , Granuloma/diagnostic imaging , Granuloma/drug therapy , Leishmaniasis/complications , Leishmaniasis/diagnostic imaging , Leishmaniasis/drug therapy , Male , Rhinitis/complications , Rhinitis/diagnostic imaging , Rhinitis/drug therapy , Tomography, X-Ray Computed/veterinary
3.
Emerg Infect Dis ; 25(12): 1-4, 2019 12.
Article in English | MEDLINE | ID: mdl-31742505

ABSTRACT

Dogs are the main reservoir of Leishmania infantum and in some countries have been regularly culled as part of government policy to control visceral leishmaniasis. At the 13th Symposium of the Companion Vector-Borne Diseases World Forum in Windsor, UK, March 19-22, 2018, we consolidated a consensus statement regarding the usefulness of dog culling as a means of controlling visceral leishmaniasis. The statement highlighted the futility of culling infected dogs, whether healthy or sick, as a measure to control the domestic reservoir of L. infantum and reduce the risk for visceral leishmaniasis.


Subject(s)
Dog Diseases/epidemiology , Dog Diseases/prevention & control , Leishmaniasis/veterinary , Animals , Disease Reservoirs/veterinary , Dog Diseases/parasitology , Dog Diseases/transmission , Dogs , Leishmaniasis, Visceral/veterinary
4.
Vet Radiol Ultrasound ; 59(5): E50-E55, 2018 Sep.
Article in English | MEDLINE | ID: mdl-28233385

ABSTRACT

A 7-year-old crossbreed dog presented for lameness with diffuse soft tissue swelling in the right fore limb. Radiographs identified increased opacity of medullary cavity involving the radius and ulna. Whole-body computed tomography (CT) revealed mineral attenuation in the medullary cavity of multiple bones. Histopathology of the right distal tibia showed a fibrocartilaginous matrix occupying intertrabecular spaces. The final diagnosis was enchondromatosis. Long-term favorable progression of the dog's clinical condition further supported the benign histopathologic classification. This is the fifth case of canine enchondromatosis reported so far and the first documentation of further characterization with CT.


Subject(s)
Dog Diseases/diagnostic imaging , Enchondromatosis/veterinary , Radius/diagnostic imaging , Tibia/diagnostic imaging , Ulna/diagnostic imaging , Animals , Dogs , Enchondromatosis/diagnostic imaging , Male , Radiography/veterinary , Radius/pathology , Tibia/pathology , Tomography, X-Ray Computed/veterinary , Ulna/pathology
5.
Gastroenterol Hepatol ; 41(1): 54-62, 2018 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-28882616

ABSTRACT

OBJECTIVE: To define clinical screening criteria for spondyloarthritis (SpA) in patients with inflammatory bowel disease (IBD) and vice versa, which can be used as a reference for referring them to the rheumatology or gastroenterology service. METHOD: Systematic literature review and a two-round Delphi method. The scientific committee and the expert panel were comprised of 2 rheumatologists and 2 gastroenterologists, and 7 rheumatologists and 7 gastroenterologists, respectively. The scientific committee defined the initial version of the criteria, taking into account sensitivity, specificity, standardization and ease of application. Afterwards, members of the expert panel assessed each item in a two-round Delphi survey. Items that met agreement in the first or second round were included in the final version of the criteria. RESULTS: Positive screening for SpA if at least one of the following is present: onset of chronic low back pain before 45 years of age; inflammatory low back pain or alternating buttock pain; HLA-B27 positivity; sacroiliitis on imaging; arthritis; heel enthesitis; dactylitis. Positive screening for IBD in the presence of one of the major criteria or at least two minor criteria. Major: rectal bleeding; chronic diarrhea with organic characteristics; perianal disease. Minor: chronic abdominal pain; iron deficiency anemia or iron deficiency; extraintestinal manifestations; fever or low grade fever, of unknown origin and duration >1week; unexplained weight loss; family history of IBD. CONCLUSION: Screening criteria for IBD in patients with SpA, and vice versa, have been developed. These criteria will be useful for early detection of both diseases.


Subject(s)
Gastroenterology , Inflammatory Bowel Diseases/diagnosis , Referral and Consultation/standards , Rheumatology , Spondylarthritis/diagnosis , Symptom Assessment/standards , Delphi Technique , Diarrhea/etiology , Early Diagnosis , Gastrointestinal Hemorrhage/etiology , HLA-B27 Antigen/analysis , Humans , Inflammatory Bowel Diseases/complications , Low Back Pain/etiology , Rectum , Sacroiliitis/etiology , Sensitivity and Specificity , Spondylarthritis/complications
6.
Rheumatol Int ; 37(11): 1817-1823, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28918450

ABSTRACT

The objective of the study was to study the clinical utility of the Ankylosing Spondylitis Disease Activity Score (ASDAS) for the assessment of disease activity in ankylosing spondylitis (AS) patients, compared to the Bath Ankylosing Spondylitis Activity Index (BASDAI). This was a prospective longitudinal observational study in patients with AS (NY-modified criteria) from 23 Spanish centers. Physical and analytical data; global, lumbar, and nocturnal pain; ASDAS, BASDAI and minimally acceptable clinical status (PASS) were collected. Psychometric characteristics of both indexes were analyzed: construct validity (convergent and divergent), discriminant capacity, criterion validity (global physician and patient assessment), and sensitivity to change. The study involved 127 patients (19.7% attrition). Both BASDAI and ASDAS showed a higher correlation with patient's global assessment (r = 0.76 and 0.70, respectively) than with physician's global assessment (r = 0.67 and 0.57). Both scores allowed discriminating patients with an acceptable clinical status, although BASDAI to a greater extent than ASDAS (Cohen δ 1.72 vs 0.88 for the medical PASS). Both scores showed sensitivity to change in patients who changed from an unacceptable symptomatic state to acceptable according to PASS criteria (physician and patient) and by BASDAI 50 response criteria (Cohen δ > 0.80). BASDAI showed better criterion validity than ASDAS, both for the patient PASS (AUC 0.85 vs 0.79) and for the physician's (AUC 0.90 vs 0.79). ASDAS shows adequate performance for disease activity in patients with AS; however, in this study, its psychometric properties do not present advantages over BASDAI in terms of criterion validity, sensitivity to change or discriminative capacity; replacement of BASDAI by ASDAS is not supported by the data.


Subject(s)
Severity of Illness Index , Spondylitis, Ankylosing/diagnosis , Adult , Female , Humans , Male , Middle Aged , Prospective Studies , Psychometrics , Spondylitis, Ankylosing/psychology
7.
Can Vet J ; 58(12): 1287-1293, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29203938

ABSTRACT

This retrospective study investigated the impact of amino acid supplementation on body weight, serum albumin, creatinine and urea concentrations, and urine protein-to-creatinine (UPC) ratio in proteinuric dogs with chronic kidney disease (CKD). Forty-six client-owned azotemic dogs with spontaneous proteinuric CKD already on a renal diet and in therapy with enalapril were included. After approximately 1 month of treatment (baseline), 29 dogs received oral amino acid supplementation daily (group A) and 17 dogs did not (group B). The parameters under investigation were determined at baseline and after 4 to 8 weeks in both groups. Compared to baseline, body weight and serum albumin increased (P < 0.01, P < 0.05, respectively) at follow-up in group A, but did not change in group B. Serum creatinine concentration did not change in both groups; urea concentration (P < 0.05) and UPC ratio (P < 0.01) decreased in group B, but not in group A. Supplementation with amino acids increased body weight and serum albumin concentration in these dogs but it might have prevented a decrease in proteinuria and urea concentration.


Effets à court terme de la supplémentation alimentaire avec des acides aminés chez les chiens atteints de la maladie rénale chronique protéinurique. Cette étude rétrospective a étudié l'impact de la supplémentation avec des acides aminés sur le poids corporel, l'albumine sérique, les concentrations de créatinine et d'urée et le rapport protéines/créatinine urinaire (UPC) chez les chiens albuminuriques atteints de maladie rénale chronique (MRC). Quarante-six chiens azotémiques, appartenant à des clients, atteints de MRC albuminurique spontanée consommant déjà une diète rénale et un traitement d'énalapril ont été inclus. Environ 1 mois après le traitement (données de référence), 29 chiens ont reçu une supplémentation quotidienne aux acides aminés (groupe A) et 17 ne l'ont pas reçu (groupe B). Les paramètres à l'étude étaient déterminés aux données de référence et après 4 à 8 semaines dans les deux groupes. Comparativement aux données de référence, le poids corporel et l'albumine sérique ont augmenté (P < 0,01, P < 0,05, respectivement) au suivi dans le groupe A, mais n'ont pas changé dans le groupe B. La concentration de créatinine sérique n'a pas changé dans les deux groupes; la concentration d'urée (P < 0,05) et le rapport d'UPC (P < 0,01) ont baissé dans le groupe B, mais non dans le groupe A. La supplémentation avec des acides aminés a augmenté le poids corporel et la concentration d'albumine sérique chez ces chiens mais elle peut avoir empêché une baisse de la concentration de protéinurie et d'urée.(Traduit par Isabelle Vallières).


Subject(s)
Amino Acids/therapeutic use , Dietary Supplements , Dog Diseases/diet therapy , Proteinuria/veterinary , Renal Insufficiency, Chronic/veterinary , Animals , Creatinine/blood , Dogs , Female , Male , Proteinuria/ethnology , Renal Insufficiency, Chronic/diet therapy , Retrospective Studies , Serum Albumin/analysis
8.
BMC Vet Res ; 12(1): 213, 2016 Sep 22.
Article in English | MEDLINE | ID: mdl-27658466

ABSTRACT

BACKGROUND: There is a growing concern regarding the increase of antimicrobial resistant bacteria in companion animals. Yet, there are no studies comparing the resistance levels of these organisms in European countries. The aim of this study was to investigate geographical and temporal trends of antimicrobial resistant bacteria causing urinary tract infection (UTI) in companion animals in Europe. The antimicrobial susceptibility of 22 256 bacteria isolated from dogs and cats with UTI was determined. Samples were collected between 2008 and 2013 from 16 laboratories of 14 European countries. The prevalence of antimicrobial resistance of the most common bacteria was determined for each country individually in the years 2012-2013 and temporal trends of bacteria resistance were established by logistic regression. RESULTS: The aetiology of uropathogenic bacteria differed between dogs and cats. For all bacterial species, Southern countries generally presented higher levels of antimicrobial resistance compared to Northern countries. Multidrug-resistant Escherichia coli were found to be more prevalent in Southern countries. During the study period, the level of fluoroquinolone-resistant E. coli isolated in Belgium, Denmark, France and the Netherlands decreased significantly. A temporal increase in resistance to amoxicillin-clavulanate and gentamicin was observed among E. coli isolates from the Netherlands and Switzerland, respectively. Other country-specific temporal increases were observed for fluoroquinolone-resistant Proteus spp. isolated from companion animals from Belgium. CONCLUSIONS: This work brings new insights into the current status of antimicrobial resistance in bacteria isolated from companion animals with UTI in Europe and reinforces the need for strategies aiming to reduce resistance.

9.
Rheumatol Int ; 36(3): 365-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26597492

ABSTRACT

The aim of this study was to assess nailfold capillaroscopic (NC) findings in patients with primary Sjögren's syndrome (PSS) with and without Raynaud's phenomenon (RP) as well as in the presence of positive anti-SSA/Ro and anti-SSB/La antibodies. Videocapillaroscopy was performed in 150 patients with PSS. Data collected included demographics, presence of RP, PSS symptoms, antinuclear antibodies, rheumatoid factor, anti-Ro, anti-La, anti-CCP, salivary scintigraphy, labial biopsy, and NC findings. RP was present in 32% of PSS, keratoconjunctivitis sicca in 91%, oral xerosis in 93%, and skin or genital xerosis in 53%. In patients with positive anti-SSA/Ro (75%) and positive anti-SSB/La (40%), NC showed normal findings in 53% of cases and non-specific in 36%. In patients with PSS, NC was normal in 51% of cases and non-specific in 34%. Scleroderma pattern was found in 14 patients. RP associated with PSS had non-specific capillaroscopy in 40% of cases (p = 0.1). Pericapillary haemorrhages (p = 0.06) and capillary thrombosis (p = 0.2) were not increased, but more dilated capillaries were detected in 48% of cases. Patients with positive anti-Ro and/or anti-La have not a distinct NC profile. Patients with RP associated with PSS had more dilated capillaries, but neither pericapillary haemorrhages nor capillary thrombosis was observed.


Subject(s)
Antibodies, Antinuclear/blood , Microcirculation , Microscopic Angioscopy/methods , Nails/blood supply , Raynaud Disease/diagnosis , Sjogren's Syndrome/diagnosis , Video Recording , Aged , Biomarkers/blood , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Raynaud Disease/blood , Raynaud Disease/immunology , Raynaud Disease/physiopathology , Regional Blood Flow , Sjogren's Syndrome/blood , Sjogren's Syndrome/immunology , Sjogren's Syndrome/physiopathology , Spain
10.
Vet Clin Pathol ; 53(1): 122-130, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38242688

ABSTRACT

A 7-month-old intact female bearded collie dog was admitted after a 2-week history of progressive cough, inappetence, and lethargy, with no response to previous treatment with doxycycline and steroids. Mild attenuation of lung sounds in the right middle hemithorax was the only abnormality detected on physical examination. Abdominal ultrasound and thoracic radiographs were performed and revealed multifocally distributed nodules and masses, well-circumscribed and of variable size in the kidneys and pulmonary parenchyma. Ultrasound-guided fine needle aspirates of the renal and pulmonary masses were taken. A cytologic evaluation of these lesions pointed towards a malignant mesenchymal neoplasia. Euthanasia was elected due to the poor prognosis and rapid progression. The post-mortem histopathology, a positive result to IBA1 immunoperoxidase staining, and a lack of detection of infectious agents, and negative E-cadherin immunostaining enabled the final diagnosis of a disseminated histiocytic sarcoma. We report an atypical form, both in breed and age, of canine disseminated histiocytic sarcoma. While all breeds can be affected, there is a clear predisposition in some, and no cases have been previously described in bearded collies. Moreover, to the authors' knowledge, this is the youngest dog with this histiocytic disorder described to date. Disseminated histiocytic sarcoma should be considered as a differential diagnosis of multinodular tumors in dogs, regardless of the anatomic location and age of the dogs, even in puppies.


Subject(s)
Dog Diseases , Histiocytic Sarcoma , Sarcoma , Dogs , Animals , Female , Histiocytic Sarcoma/pathology , Histiocytic Sarcoma/veterinary , Sarcoma/pathology , Sarcoma/veterinary , Biopsy, Fine-Needle/veterinary , Histiocytes/pathology , Dog Diseases/diagnosis
11.
Vet Clin Pathol ; 53(2): 202-208, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38622430

ABSTRACT

A 10-year-old neutered male Maltese dog was presented for an investigation of lymphocytosis. The dog was up-to-date on vaccinations and deworming. Physical examination did not reveal any significant abnormalities. A complete blood cell count (CBC) showed mild leukocytosis with moderate lymphocytosis, basophilia, and moderate neutropenia, but no significant left shift or toxic change. Serum biochemistry and urinalysis were unremarkable. All performed tests for infectious agents common in this geographical region were negative. No significant abnormalities were found on abdominal ultrasound examination. Multiparametric flow cytometry of peripheral blood showed a CD8+ T-cell lymphocytosis, and PCR for antigen receptor rearrangement revealed a clonal expansion of the T-cell receptor gamma chain genes. A clinical diagnosis of chronic lymphocytic leukemia (CLL) was made, and follow-up was recommended. On Day 48 post-presentation, the CBC showed mild non-regenerative anemia (NRA), moderate leucocytosis due to moderate to marked lymphocytosis, basophilia, and a marked increase in hyposegmented neutrophils with mild toxic change in the absence of neutrophilia or neutropenia. Treatment with chlorambucil and prednisolone was initiated. On Days 87 and 197 post-presentation, the CBC showed mild NRA, with progressively decreasing numbers of hyposegmented neutrophils. The dog remained without clinical signs. Basophilia and probable pseudo-Pelger-Huët anomaly were possibly secondary to CLL. To the authors' knowledge, this is the first report of these two hematologic conditions secondary to CLL in dogs. Recognition of a pseudo-Pelger-Huët anomaly is clinically relevant to avoid misinterpretation as a marked left shift due to severe inflammation and prevent unnecessary urgent therapeutic actions.


Subject(s)
Dog Diseases , Leukemia, Lymphocytic, Chronic, B-Cell , Pelger-Huet Anomaly , Animals , Dogs , Male , Leukemia, Lymphocytic, Chronic, B-Cell/veterinary , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Dog Diseases/pathology , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Pelger-Huet Anomaly/veterinary , Pelger-Huet Anomaly/pathology , Lymphocytosis/veterinary , Lymphocytosis/pathology , Leukocytosis/veterinary , Leukocytosis/pathology
12.
Animals (Basel) ; 14(7)2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38612252

ABSTRACT

The erythrocyte sedimentation rate (ESR) has been used in canine medicine in several disorders, above all, to evaluate levels of inflammation. This study evaluated the ESR in canine leishmaniosis (CanL) and other inflammatory conditions. Three groups of dogs were examined: CanL affected dogs without clinical signs (INFECTED group, #25) or with clinical signs (SICK group, #43) and dogs affected by acute or acute-on-chronic conditions (OTHER DISEASE group, #65). The ESR was compared with acute phase proteins or reactants either positive or negative (leukogram, fibrinogen, iron, unsaturated iron binding capacity, ferritin, haptoglobin, and albumin) and immunological markers (gamma-globulins, IgG, and IgM). The ESR was higher in the SICK group than in the INFECTED group (median 39 vs. 11 mm/h; p < 0.0001), as well as in the OTHER DISEASE than in the INFECTED groups (median 41 vs. 11 mm/h; p < 0.0001). The ESR appeared outside the reference range for all dogs in the SICK and OTHER DISEASE groups and almost with similar values (mm/h; median 39, 95% CI 31-51 vs. 41, 95% CI 12-87; p > 0.05). The extent of changes in ESR can help to establish the severity of CanL and other inflammatory disorders. As a point-of-care test, the ESR can be used to screen dogs for unhealthy conditions, and its values correlate with the severity of any disease, including CanL.

13.
J Vet Intern Med ; 38(4): 1958-1981, 2024.
Article in English | MEDLINE | ID: mdl-38752421

ABSTRACT

Immune thrombocytopenia (ITP) is the most common acquired primary hemostatic disorder in dogs. Immune thrombocytopenia less commonly affects cats but is an important cause of mortality and treatment-associated morbidity in both species. Immune thrombocytopenia remains a diagnosis of exclusion for which diagnostic guidelines are lacking. Primary, or non-associative, ITP refers to autoimmune platelet destruction. Secondary, or associative, ITP arises in response to an underlying disease trigger. However, evidence for which comorbidities serve as ITP triggers has not been systematically evaluated. To identify key diagnostic steps for ITP and important comorbidities associated with secondary ITP, we developed 12 Population Evaluation/Exposure Comparison Outcome (PECO) format questions. These questions were addressed by evidence evaluators utilizing a literature pool of 287 articles identified by the panelists using a structured search strategy. Evidence evaluators, using panel-designed templates and data extraction tools, summarized evidence and created guideline recommendations that then were integrated by diagnosis and comorbidity domain chairs. The revised PECO responses underwent a Delphi survey process to reach consensus on final guidelines. A combination of panel expertise and PECO responses were employed to develop algorithms for diagnosis of ITP in dogs and cats, which also underwent 4 iterations of Delphi review. Comorbidity evidence evaluators employed an integrated measure of evidence (IME) tool to determine evidence quality for each comorbidity; IME values combined with evidence summaries for each comorbidity were integrated to develop ITP screening recommendations, which also were subjected to Delphi review. Commentary was solicited from multiple relevant professional organizations before finalizing the consensus. The final consensus statement provides clinical guidelines for the diagnosis of, and underlying disease screening for, ITP in dogs and cats. The systematic consensus process identified numerous knowledge gaps that should guide future studies. This statement is a companion manuscript to the ACVIM Consensus Statement on the Treatment of Immune Thrombocytopenia.


Subject(s)
Cat Diseases , Dog Diseases , Purpura, Thrombocytopenic, Idiopathic , Dogs , Animals , Cats , Dog Diseases/diagnosis , Cat Diseases/diagnosis , Purpura, Thrombocytopenic, Idiopathic/veterinary , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Consensus
14.
J Am Anim Hosp Assoc ; 49(4): 231-6, 2013.
Article in English | MEDLINE | ID: mdl-23690493

ABSTRACT

A retrospective study was performed using 53 client owned dogs with leishmaniasis to determine whether the degree of proteinuria, evaluated by the urine protein/creatinine ratio (UP/C), changes following treatment with meglumine antimoniate and allopurinol. Medical records of dogs with leishmaniasis in clinical stage C (according to the Canine Leishmaniasis Working Group staging system) and either proteinuric or borderline proteinuric (according to the International Renal Interest Society [IRIS] staging system) were reviewed. All dogs were treated with meglumine antimoniate and allopurinol for 4-8 wk. After treatment, UP/C, total protein, and total globulin significantly decreased and albumin and the albumin/globulin ratio (A/G) increased. After treatment, 7 of the 53 dogs (13.4%) became nonproteinuric following either a proteinuric or borderline proteinuric stage. Moreover, 12 of the 53 proteinuric dogs (22.6%) changed their stage to borderline proteinuric. The antileishmaniasis treatment with meglumine antimoniate in combination with allopurinol in dogs significantly reduced the degree of proteinuria in a short period of time. The results of the current study may be useful to the veterinary practitioner in the clinical management of canine leishmaniasis (CanL) in dogs with proteinuric chronic kidney disease.


Subject(s)
Allopurinol/therapeutic use , Dog Diseases/drug therapy , Leishmaniasis/veterinary , Meglumine/therapeutic use , Organometallic Compounds/therapeutic use , Proteinuria/veterinary , Animals , Creatinine/urine , Dog Diseases/urine , Dogs , Female , Leishmaniasis/complications , Leishmaniasis/drug therapy , Leishmaniasis/urine , Male , Meglumine Antimoniate , Proteinuria/etiology , Retrospective Studies , Serum Albumin/analysis
15.
Parasit Vectors ; 16(1): 77, 2023 Feb 27.
Article in English | MEDLINE | ID: mdl-36850014

ABSTRACT

BACKGROUND: Wolbachia is a Gram-negative endosymbiont associated with several species of arthropods and filarioid nematodes, including Dirofilaria immitis. This endosymbiont may elicit a Th1 response, which is a component of the immunity against Leishmania infantum. METHODS: To investigate the interactions between Wolbachia of D. immitis and L. infantum in naturally infected dogs and cytokine circulation, dogs without clinical signs (n = 187) were selected. Dogs were tested for microfilariae (mfs) by Knott, for female antigens of D. immitis by SNAP, and for anti-L. infantum antibodies by IFAT and assigned to four groups. Dogs of group 1 (G1) and 2 (G2) were positive for D. immitis and positive or negative to L. infantum, respectively. Dogs of group 3 (G3) and 4 (G4) were negative to D. immitis and positive or negative to L. infantum, respectively. Wolbachia and L. infantum DNA was quantified by real-time PCR (qPCR) in dog blood samples. A subset of dogs (n = 65) was examined to assess pro- and anti-inflammatory cytokine production using an ELISA test. RESULTS: Of 93 dogs positive to D. immitis with circulating mfs, 85% were positive to Wolbachia, with the highest amount of DNA detected in G1 and the lowest in dogs with low mfs load in G1 and G2. Among dogs positive to L. infantum, 66% from G1 showed low antibody titer, while 48.9% from G3 had the highest antibody titer. Of 37 dogs positive to Wolbachia from G1, 26 (70.3%) had low antibody titers to L. infantum (1:160). Among cytokines, TNFα showed the highest mean concentration in G1 (246.5 pg/ml), IFNγ being the one most represented (64.3%). IL-10 (1809.5 pg/ml) and IL-6 (123.5 pg/ml) showed the highest mean concentration in dogs from G1. A lower percentage of dogs producing IL-4 was observed in all groups examined, with the highest mean concentration (2794 pg/ml) recorded in G2. CONCLUSION: Results show the association of D. immitis and Wolbachia with the lower antibody titers of L. infantum in co-infected dogs, suggesting the hypothesis that the endosymbiont may affect the development of the patent leishmaniosis. However, due to the limitations associated with the heterogeneity of naturally infected dogs in field conditions, results should be validated by investigation on experimental models.


Subject(s)
Dirofilaria immitis , Leishmania infantum , Wolbachia , Female , Animals , Dogs , Cytokines
16.
Vet Clin Pathol ; 52(3): 507-513, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37202832

ABSTRACT

An 11-year-old neutered female Golden Retriever was referred for investigation of marked increases in liver enzyme activities. Abdominal ultrasound revealed a large pedunculated liver mass. Diagnosis of hepatocellular adenoma (HCA) was made when the mass was excised after a first unsuccessful attempt through ultrasound-guided core-needle biopsy. One and a half years after presentation, a nodule embedded between muscles of the abdominal wall appeared. The mass was first diagnosed as a well-differentiated hepatocellular carcinoma (HCC) through cytologic examination, which was later confirmed with histopathology. Ki 67 immunostaining of the abdominal wall nodule showed an increased immunoreactivity compared with the liver mass. Therefore, the present case documents the first needle-tract seeding of a hepatocellular epithelial tumor with possible malignant transformation of HCA into a well-differentiated HCC in a dog.


Subject(s)
Adenoma, Liver Cell , Carcinoma, Hepatocellular , Dog Diseases , Liver Neoplasms , Dogs , Female , Animals , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/veterinary , Carcinoma, Hepatocellular/pathology , Adenoma, Liver Cell/diagnosis , Adenoma, Liver Cell/veterinary , Liver Neoplasms/diagnosis , Liver Neoplasms/veterinary , Neoplasm Seeding , Dog Diseases/diagnostic imaging , Dog Diseases/surgery
17.
Rheumatology (Oxford) ; 51(8): 1471-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22495925

ABSTRACT

OBJECTIVE: The aim of this study was to analyse if single nucleotide polymorphisms (SNPs) inside and outside the MHC region might improve the prediction of radiographic severity in AS. METHODS: A cross-sectional multi-centre study was performed including 473 Spanish AS patients previously diagnosed with AS following the Modified New York Criteria and with at least 10 years of follow-up from the first symptoms of AS. Clinical variables and 384 SNPs were analysed to predict radiographic severity [BASRI-total (BASRI-t) corrected for the duration of AS since first symptoms] using multivariate forward logistic regression. Predictive power was measured by the area under the receiver operating characteristic curve (AUC), specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV). RESULTS: The model with the best fit measured radiographic severity as the BASRI-t 60th percentile and combined eight variables: male gender, older age at disease onset and six SNPs at ADRB1 (rs1801253), NELL1 (rs8176785) and MHC (rs1634747, rs9270986, rs7451962 and rs241453) genes. The model predictive power was defined by AUC = 0.76 (95% CI 0.71, 0.80), being significantly better than the model with only clinical variables, AUC = 0.68 (95% CI 0.63, 0.73), P = 0.0004. Internal split-sample analysis proved the validation of the model. Patient genotype for SNPs outside the MHC region, inside the MHC region and clinical variables account for 26, 38 and 36%, respectively, of the explained variability on radiographic severity prediction. CONCLUSION: Prediction of radiographic severity in AS based on clinical variables can be significantly improved by including SNPs both inside and outside the MHC region.


Subject(s)
Major Histocompatibility Complex/genetics , Nerve Tissue Proteins/genetics , Polymorphism, Single Nucleotide/genetics , Receptors, Adrenergic, beta-1/genetics , Severity of Illness Index , Spondylitis, Ankylosing/diagnostic imaging , Spondylitis, Ankylosing/genetics , Adult , Calcium-Binding Proteins , Cohort Studies , Cross-Sectional Studies , Female , Follow-Up Studies , Genetic Predisposition to Disease , Humans , Logistic Models , Male , Middle Aged , Predictive Value of Tests , ROC Curve , Radiography , Sensitivity and Specificity , Spondylitis, Ankylosing/pathology
18.
Parasit Vectors ; 15(1): 105, 2022 May 10.
Article in English | MEDLINE | ID: mdl-35534857

ABSTRACT

BACKGROUND: Cranial cruciate ligament rupture (CCLR) results from a multifactorial degenerative process that leads to rupture of the ligament. Vector-borne pathogens (VBP) in dogs can induce joint disease but their role in CCLR has not been previously investigated. The aim of the present work is to evaluate the prevalence of VBP in dogs with CCLR. METHODS: This was a prospective study that included 46 dogs presented for CCLR surgical treatment and 16 control dogs euthanized for diseases unrelated to the joints. Specimens collected included blood, synovial fluid, and synovial membrane biopsy. Pathogen testing consisted of serology for Leishmania infantum (quantitative ELISA), Ehrlichia canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, and Dirofilaria immitis (4DX IDEXX test), and PCR for L. infantum, Ehrlichia/Anaplasma spp., Bartonella spp., piroplasms (Babesia spp. and Theileria spp.), and filariae (D. immitis, Dirofilaria repens, Acanthocheilonema dracunculoides, Acanthocheilonema reconditum, and Cercopithifilaria spp.) on both EDTA-whole blood (EB) and synovial fluid (SF) samples. SF cytology and histopathological evaluation of synovial membrane were also performed. RESULTS: The prevalence of VBP was 19.6% in the CCLR group and 18.8% in the control group, with no statistical difference among them. The presence of synovitis was not more frequent in CCLR dogs (45.6%) than in control dogs (43.7%). Lymphoplasmacytic infiltration was the most common inflammatory pattern detected in the joints of both groups of dogs. CONCLUSIONS: This study failed to demonstrate a role of canine VBP in CCLR or the presence or different pattern of joint inflammation in pathogen-positive dogs.


Subject(s)
Anaplasmosis , Dirofilaria immitis , Dog Diseases , Ehrlichiosis , Anaplasma/genetics , Anaplasmosis/epidemiology , Animals , Anterior Cruciate Ligament , Dog Diseases/epidemiology , Dogs , Ehrlichia , Ehrlichiosis/veterinary , Prospective Studies , Seroepidemiologic Studies
19.
Parasit Vectors ; 15(1): 253, 2022 Jul 11.
Article in English | MEDLINE | ID: mdl-35818075

ABSTRACT

BACKGROUND: There is limited information about feline leishmaniosis (FeL) management in clinical practice. Leishmania infantum is the species of Leishmania most frequently reported in both dogs and cats in countries of the Mediterranean region (henceforth 'Mediterranean countries'), Central and South America, and Iran. This study was conducted to provide veterinary clinicians with an updated overview of evidence-based information on leishmaniosis in cats. METHODS: A review was performed using PubMed, Science Direct, Google Scholar and Web of Science. Case reports of FeL caused by L. infantum were sought for the period 1912 to 1 June 2021. RESULTS: Sixty-three case reports are included in this review. Fifty-nine out of the 63 cats were from Europe, mostly from Mediterranean countries (88.9%). Most of them were domestic short-haired cats (90%) with a mean age of 7.9 years, and had access to the outdoors (77.3%). Sixty-six percent of the cats had comorbidities, of which feline immunodeficiency virus infection was the most frequent (37.7%). Dermatological lesions (69.8%) was the most frequent clinical sign, and hyperproteinemia (46.3%) the most frequent clinicopathological abnormality. Serology was the most performed diagnostic method (76.2%) and was positive for 93.7% of cats. Medical treatment was applied in 71.4% of cats, and allopurinol was the most used drug (74.4%). Survival time was greater for treated cats (520 days; 71.4% of cats) than non-treated cats (210 days; 25.4%). CONCLUSIONS: The majority of the cats had comorbidities, of which feline immunodeficiency virus was the most frequent. Dermatological lesions were frequently reported, and systemic clinical signs and clinicopathological abnormalities were also common. Serology may be useful for the diagnosis of FeL in clinical practice, and a positive titer of ≥ 1/40 may be a useful cut-off for sick cats. The reported treatments and dosages varied, but there was a good clinical response and longer survival in most of the cats treated with allopurinol monotherapy.


Subject(s)
Cat Diseases , Dog Diseases , Leishmania infantum , Leishmaniasis, Visceral , Leishmaniasis , Allopurinol/therapeutic use , Animals , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Cat Diseases/epidemiology , Cats , Dog Diseases/drug therapy , Dog Diseases/epidemiology , Dogs , Leishmaniasis/drug therapy , Leishmaniasis/epidemiology , Leishmaniasis/veterinary , Leishmaniasis, Visceral/veterinary
20.
Comp Immunol Microbiol Infect Dis ; 83: 101783, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35240487

ABSTRACT

Xanthinuria is a significant adverse effect in dogs on long-term allopurinol for treatment of leishmaniosis. The study aims to investigate how the Iberian veterinary community (IVC) identifies, manages, and proactively prevents xanthinuria secondary to allopurinol treatment. A cross-sectional study was conducted using an online survey, translated into two languages, and disseminated to the IVC via social networking forums. Respondents were asked to share their treatment regimens, adverse effects attributed to treatment, as well as preventive and reactive measures against xanthuria. Of two-hundred and thirty respondents, 99.6% prescribe allopurinol for canine leishmaniosis. Xanthinuria was estimated to happen in less than one out of every four dogs by 91.7% of the clinicians. Xanthinuria has been detected by 71.6% of respondents at least once. Three out of every four respondents inform owners about deleterious effects of allopurinol, and 28.4% consider implementing a change in diet in advance of treatment as a proactive measure. To monitor xanthinuria, urinalysis and diagnostic imaging are used by 71.2% and 31% of clinicians respectively. When xanthinuria is detected, 43.2% of the respondents discontinue allopurinol, 24% replace it by nucleotide-analogs, 14.9% reduce its dosage, and 3.1% split its dosage but increase administration frequency. Additional measures are taken by 72.1% of the respondents, 59.4% of whom prescribe a low-purine diet. The IVC recognizes xanthinuria as a fairly common secondary effect of long-term allopurinol treatment in dogs with leishmaniosis and recommends periodically monitoring and preventive measures.


Subject(s)
Dog Diseases , Leishmaniasis , Allopurinol/adverse effects , Animals , Cross-Sectional Studies , Dog Diseases/drug therapy , Dogs , Leishmaniasis/drug therapy , Leishmaniasis/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL